These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 36113962)

  • 21. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
    Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
    Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil.
    Neumann I; Fuhrmann H; Fang IF; Jaeger A; Bayer P; Kovarik J
    Nephrol Dial Transplant; 2008 Nov; 23(11):3514-20. PubMed ID: 18586766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study.
    Loarce-Martos J; García-Fernández A; López-Gutiérrez F; García-García V; Calvo-Sanz L; Del Bosque-Granero I; Terán-Tinedo MA; Boteanu A; Bachiller-Corral J; Vázquez-Díaz M
    Rheumatol Int; 2020 Dec; 40(12):2015-2021. PubMed ID: 32945944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
    Mino Y; Naito T; Matsushita T; Otsuka A; Ushiyama T; Ozono S; Hishida A; Kagawa Y; Kawakami J
    Ther Drug Monit; 2008 Dec; 30(6):656-61. PubMed ID: 18978521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycophenolic acid in psoriasis.
    Spatz S; Rudnicka A; McDonald CJ
    Br J Dermatol; 1978 Apr; 98(4):429-35. PubMed ID: 346042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycophenolic Acid Trough Concentration and Dose Are Associated with Hematologic Abnormalities but Not Rejection in Kidney Transplant Recipients.
    Jung HY; Lee S; Jeon Y; Choi JY; Cho JH; Park SH; Kim YL; Kim HK; Huh S; Won DI; Kim CD
    J Korean Med Sci; 2020 Jun; 35(24):e185. PubMed ID: 32567256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant Correlations between p-Cresol Sulfate and Mycophenolic Acid Plasma Concentrations in Adult Kidney Transplant Recipients.
    Rong Y; Colbourne P; Gourishankar S; Kiang TKL
    Clin Drug Investig; 2022 Mar; 42(3):207-219. PubMed ID: 35182318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mortality and associated risk factors of COVID-19 infection in dialysis patients in Qatar: A nationwide cohort study.
    Ghonimi TAL; Alkad MM; Abuhelaiqa EA; Othman MM; Elgaali MA; Ibrahim RAM; Joseph SM; Al-Malki HA; Hamad AI
    PLoS One; 2021; 16(7):e0254246. PubMed ID: 34293004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study.
    Álvaro Gracia JM; Sanchez-Piedra C; Manero J; Ruiz-Lucea ME; López-Vives L; Bohorquez C; Martinez-Barrio J; Bonilla G; Vela P; García-Villanueva MJ; Navío-Marco MT; Pavía M; Galindo M; Erausquin C; Gonzalez-Gay MA; Rua-Figueroa I; Pego-Reigosa JM; Castrejon I; Sanchez-Costa JT; González-Dávila E; Diaz-Gonzalez F;
    RMD Open; 2021 Dec; 7(3):. PubMed ID: 34887346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal mycophenolic acid and mycophenolic acid glucuronide levels at the early period after kidney transplantation are the key contributors to improving long-term outcomes.
    Baczkowska T; Sadowska A; Perkowska-Ptasinska A; Lewandowski Z; Cieciura T; Pazik J; Wazna E; Kozinska OP; Nowacka Cieciura E; Chmura A; Durlik M
    Transplant Proc; 2009 Oct; 41(8):3019-23. PubMed ID: 19857666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry.
    Langone A; Doria C; Greenstein S; Narayanan M; Ueda K; Sankari B; Pankewycz O; Shihab F; Chan L
    Clin Transplant; 2013; 27(1):15-24. PubMed ID: 22861144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil.
    Zahr N; Arnaud L; Marquet P; Haroche J; Costedoat-Chalumeau N; Hulot JS; Funck-Brentano C; Piette JC; Amoura Z
    Arthritis Rheum; 2010 Jul; 62(7):2047-54. PubMed ID: 20506558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inadequate mycophenolic acid exposure and acute rejection in kidney transplantation.
    Sánchez-Fructuoso AI; de la Higuera MA; Giorgi M; Ramos F; Garcia Ledesma P; Calvo N; Pérez-Flores I; Barrientos A
    Transplant Proc; 2009; 41(6):2104-5. PubMed ID: 19715844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased short-term risk of cardiovascular events in inflammatory rheumatic diseases: results from a population-based cohort.
    Da Silva Domingues V; Rodrigues AM; Dias SS; Delgado L; Barkoudah E; Branco J; Canhão H
    Rheumatol Int; 2021 Feb; 41(2):311-318. PubMed ID: 33388968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipients.
    Fukuda T; Goebel J; Cox S; Maseck D; Zhang K; Sherbotie JR; Ellis EN; James LP; Ward RM; Vinks AA
    Ther Drug Monit; 2012 Dec; 34(6):671-9. PubMed ID: 23131697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonsteroidal anti-inflammatory drugs may reduce enterohepatic recirculation of mycophenolic acid in patients with childhood-onset systemic lupus erythematosus.
    Fukuda T; Brunner HI; Sagcal-Gironella AC; Vinks AA
    Ther Drug Monit; 2011 Oct; 33(5):658-62. PubMed ID: 21860343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms of UGT1A8, UGT1A9 and HNF-1α and gastrointestinal symptoms in renal transplant recipients taking mycophenolic acid.
    Vu D; Tellez-Corrales E; Yang J; Qazi Y; Shah T; Naraghi R; Hutchinson IV; Min DI
    Transpl Immunol; 2013 Dec; 29(1-4):155-61. PubMed ID: 23721685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis.
    Abd Rahman AN; Tett SE; Abdul Gafor HA; McWhinney BC; Staatz CE
    Br J Clin Pharmacol; 2015 Nov; 80(5):1064-75. PubMed ID: 25959850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.
    Tett SE; Saint-Marcoux F; Staatz CE; Brunet M; Vinks AA; Miura M; Marquet P; Kuypers DR; van Gelder T; Cattaneo D
    Transplant Rev (Orlando); 2011 Apr; 25(2):47-57. PubMed ID: 21190834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
    Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
    Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.